B cell differentiation factor production in systemic lupus erythematosus. 1988

R J Warrington
Rheumatic Disease Unit Research Laboratory, University of Manitoba, Winnipeg, Canada.

Spontaneous and mitogen stimulated B cell differentiation factor (BCDF) production by peripheral blood lymphocytes (PBL) from patients with systemic lupus erythematosus (SLE) was compared with that of normal control subjects. BCDF production was measured by a cellular interleukin assay in which a BCDF responsive cell line was cocultured with increasing numbers of PBL from the donor populations. It was found that no significant differences occurred in BCDF production by SLE and normal PBL under the conditions used. Indeed there was a trend toward decreased BCDF release from SLE PBL. This would support the hypothesis that human SLE is the result of enhanced B cell responsiveness to helper cell factors rather than due to increased release of such factors.

UI MeSH Term Description Entries
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays
D015847 Interleukin-4 A soluble factor produced by activated T-LYMPHOCYTES that induces the expression of MHC CLASS II GENES and FC RECEPTORS on B-LYMPHOCYTES and causes their proliferation and differentiation. It also acts on T-lymphocytes, MAST CELLS, and several other hematopoietic lineage cells. B-Cell Growth Factor-I,B-Cell Stimulatory Factor-1,Binetrakin,IL-4,Mast Cell Growth Factor-2,B Cell Stimulatory Factor-1,B-Cell Growth Factor-1,B-Cell Proliferating Factor,B-Cell Stimulating Factor-1,B-Cell Stimulatory Factor 1,BCGF-1,BSF-1,IL4,MCGF-2,B Cell Growth Factor 1,B Cell Growth Factor I,B Cell Proliferating Factor,B Cell Stimulating Factor 1,B Cell Stimulatory Factor 1,Interleukin 4,Mast Cell Growth Factor 2

Related Publications

R J Warrington
December 2018, Journal, genetic engineering & biotechnology,
R J Warrington
July 1992, Clinical and experimental immunology,
R J Warrington
October 1990, Arthritis and rheumatism,
R J Warrington
January 2012, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology,
R J Warrington
February 2013, Clinical immunology (Orlando, Fla.),
R J Warrington
January 2003, Arthritis research & therapy,
R J Warrington
January 2007, Clinical medicine (London, England),
R J Warrington
December 2002, Annales de medecine interne,
R J Warrington
January 2018, Frontiers in immunology,
Copied contents to your clipboard!